http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2388594-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3244ba8390b1f290f4ba36389c82488b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-495 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2010-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9792cfcbfad93f8d772ab3f0d9e3221 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_688d9e88ea8368d038ce1f748cd77d97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b51292113b9b2c85563c9e40eccb918c |
| publicationDate | 2011-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2388594-A1 |
| titleOfInvention | GDF-15 based means and methods for survival and recovery prediction in acute inflammation |
| abstract | The present invention relates to the field of diagnostic measures. Specifically, it relates to a method for diagnosing whether a subject suffering from an acute inflammation and, preferably, systemic inflammtory response syndrome (SIRS), is at increased risk for mortality, said method comprises determining the amount of the biomarker GDF-15 in a sample of said subject and comparing said amount to a reference whereby an increased risk for mortality is to be diagnosed. Moreover, the present invention relates to a method for monitoring the development of acute inflammation in a subject suffering therefrom comprising determining the amount of the biomarker GDF-15 in a first and a second sample of said subject wherein said first sample has been obtained prior to said second sample and comparing the amount of GDF-15 in said first and said second sample wherein an increase in the GDF-15 amount is indicative for a diagnosis of progression of acute inflammation whereas a decrease in the amount of GDF-15 is indicative for the diagnosis of an amelioration of said acute inflammation. Further encompassed are diagnostic devices and kits for carrying out the aforementioned methods. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014343709-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2597465-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10274502-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022017980-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015063248-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3943946-A1 |
| priorityDate | 2010-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 275.